| NCT03381235 |
Exercise and RP (AVAMC and Emory) |
https://ClinicalTrials.gov/show/NCT03381235 |
Completed |
Emory University |
2018-11-28 |
| NCT03374657 |
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03374657 |
Recruiting |
Novartis |
2026-07-28 |
| NCT03368027 |
Effectiveness of a Cognitive-behavioral Program of Coping With Psychological Stress in People With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03368027 |
Completed |
Universidad de Granada |
2018-12-03 |
| NCT03328130 |
Safety and Efficacy Study in Patients With Retinitis Pigmentosa Due to Mutations in PDE6B Gene |
https://ClinicalTrials.gov/show/NCT03328130 |
Recruiting |
Horama S.A. |
2022-09-30 |
| NCT03316560 |
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations |
https://ClinicalTrials.gov/show/NCT03316560 |
Recruiting |
Applied Genetic Technologies Corp |
2023-03-31 |
| NCT03252847 |
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR) |
https://ClinicalTrials.gov/show/NCT03252847 |
Active, not recruiting |
MeiraGTx UK II Ltd |
2020-11-30 |
| NCT03248388 |
Argus II/ORCAM Device Study |
https://ClinicalTrials.gov/show/NCT03248388 |
Recruiting |
Mayo Clinic |
2021-12-31 |
| NCT03116113 |
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03116113 |
Recruiting |
NightstaRx Ltd, a Biogen Company |
2021-03-31 |
| NCT03078309 |
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients |
https://ClinicalTrials.gov/show/NCT03078309 |
Recruiting |
Hadassah Medical Organization |
2020-08-31 |
| NCT03073733 |
Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03073733 |
Active, not recruiting |
jCyte, Inc |
2020-09-30 |
| NCT03063021 |
The FIGHT-RP1 Study |
https://ClinicalTrials.gov/show/NCT03063021 |
Completed |
Johns Hopkins University |
2019-02-11 |
| NCT03057496 |
Collision Warning Device for Blind and Visually Impaired |
https://ClinicalTrials.gov/show/NCT03057496 |
Completed |
Massachusetts Eye and Ear Infirmary |
2019-11-08 |
| NCT02909985 |
Visual Activity Evoked by Infrared in Humans After Dark Adaptation |
https://ClinicalTrials.gov/show/NCT02909985 |
Completed |
University of New Mexico |
2016-08-31 |
| NCT02837640 |
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02837640 |
Recruiting |
Beirut Eye Specialist Hospital |
2017-06-30 |
| NCT02720640 |
Safety and Efficacy of the Alpha AMS Subretinal Implant |
https://ClinicalTrials.gov/show/NCT02720640 |
Completed |
University of Oxford |
2017-10-31 |
| NCT02709876 |
Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02709876 |
Active, not recruiting |
Stem Cells Arabia |
2020-09-30 |
| NCT02670980 |
Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy |
https://ClinicalTrials.gov/show/NCT02670980 |
Completed |
Pixium Vision SA |
2019-05-31 |
| NCT02614651 |
AUgmented REality for the Visually Impaired - Part 1 |
https://ClinicalTrials.gov/show/NCT02614651 |
Completed |
Centre Hospitalier Universitaire de Nīmes |
2017-04-20 |
| NCT02609165 |
Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema |
https://ClinicalTrials.gov/show/NCT02609165 |
Completed |
Ospedale San Raffaele |
2017-02-28 |
| NCT03011541 |
Stem Cell Ophthalmology Treatment Study II |
https://ClinicalTrials.gov/show/NCT03011541 |
Recruiting |
MD Stem Cells |
2022-01-31 |
| NCT03406416 |
Study of a Suprachoroidal Retinal Prosthesis |
https://ClinicalTrials.gov/show/NCT03406416 |
Active, not recruiting |
Mobius Medical Pty Ltd. |
2020-12-31 |
| NCT03845218 |
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures |
https://ClinicalTrials.gov/show/NCT03845218 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-03-30 |
| NCT02556736 |
RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02556736 |
Active, not recruiting |
Allergan |
2020-12-03 |
| NCT02464436 |
Safety and Tolerability of hRPC in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02464436 |
Recruiting |
ReNeuron Limited |
2020-01-31 |
| NCT02320812 |
Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02320812 |
Completed |
jCyte, Inc |
2017-07-19 |
| NCT02280135 |
Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02280135 |
Completed |
Red de Terapia Celular |
2017-03-31 |
| NCT02244996 |
Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum |
https://ClinicalTrials.gov/show/NCT02244996 |
Completed |
The Hong Kong Polytechnic University |
2016-04-30 |
| NCT02140164 |
Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02140164 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-11-30 |
| NCT02110225 |
A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP) |
https://ClinicalTrials.gov/show/NCT02110225 |
Completed |
Dompé Farmaceutici S.p.A |
2015-11-30 |
| NCT02086890 |
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT02086890 |
Active, not recruiting |
Nova Southeastern University |
2020-06-30 |
| NCT03326336 |
Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03326336 |
Recruiting |
GenSight Biologics |
2021-12-31 |
| NCT01866397 |
Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration |
https://ClinicalTrials.gov/show/NCT01866397 |
Completed |
Medical University of Vienna |
2002-03-31 |
| NCT01864486 |
Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy |
https://ClinicalTrials.gov/show/NCT01864486 |
Completed |
Pixium Vision SA |
2017-10-13 |
| NCT01847365 |
TES for the Treatment of RP |
https://ClinicalTrials.gov/show/NCT01847365 |
Completed |
University of Oxford |
2015-02-28 |
| NCT01837901 |
Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01837901 |
Completed |
Okuvision GmbH |
2013-08-31 |
| NCT01835002 |
Transcorneal Electrical Stimulation - Multicenter Safety Study |
https://ClinicalTrials.gov/show/NCT01835002 |
Completed |
Okuvision GmbH |
2014-07-31 |
| NCT01736059 |
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy |
https://ClinicalTrials.gov/show/NCT01736059 |
Enrolling by invitation |
University of California, Davis |
2022-01-31 |
| NCT01604356 |
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01604356 |
Completed |
Johns Hopkins University |
2013-12-31 |
| NCT01603576 |
Pilot Study of a Suprachoroidal Retinal Prosthesis |
https://ClinicalTrials.gov/show/NCT01603576 |
Completed |
Center for Eye Research Australia |
2014-08-31 |
| NCT03963154 |
Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation |
https://ClinicalTrials.gov/show/NCT03963154 |
Recruiting |
Centre d’Etude des Cellules Souches |
2021-12-15 |
| NCT01560715 |
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01560715 |
Completed |
University of Sao Paulo |
2013-01-31 |
| NCT01543906 |
Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65) |
https://ClinicalTrials.gov/show/NCT01543906 |
Completed |
QLT Inc. |
2014-07-31 |
| NCT01531348 |
Feasibility and Safety of Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01531348 |
Enrolling by invitation |
Mahidol University |
2020-12-31 |
| NCT01530659 |
Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01530659 |
Active, not recruiting |
Neurotech Pharmaceuticals |
2019-08-31 |
| NCT01521793 |
Repeated Treatments of QLT091001 in Subjects With Leber Congenital Amaurosis or Retinitis Pigmentosa (Extension of Study RET IRD 01) |
https://ClinicalTrials.gov/show/NCT01521793 |
Completed |
QLT Inc. |
2014-05-31 |
| NCT01497379 |
Safety & Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients |
https://ClinicalTrials.gov/show/NCT01497379 |
Completed |
Retina Implant AG |
2014-01-31 |
| NCT01399515 |
Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01399515 |
Completed |
Seoul National University Hospital |
2013-08-31 |
| NCT02617966 |
Rod and Cone Mediated Function in Retinal Disease |
https://ClinicalTrials.gov/show/NCT02617966 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2024-12-30 |
| NCT04356716 |
Sildenafil for Treatment of Choroidal Ischemia |
https://ClinicalTrials.gov/show/NCT04356716 |
Recruiting |
Columbia University |
2021-04-30 |
| NCT04319809 |
Object Finder for a Retinal Prosthesis |
https://ClinicalTrials.gov/show/NCT04319809 |
Active, not recruiting |
Minnesota HealthSolutions |
2021-04-30 |
| NCT04315025 |
Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04315025 |
Completed |
PT. Prodia Stem Cell Indonesia |
2019-06-20 |
| NCT04295304 |
NR600 System Retinal Prosthesis for Patients With Retinal Degenerative Diseases |
https://ClinicalTrials.gov/show/NCT04295304 |
Recruiting |
Nano Retina |
2021-12-30 |
| NCT04285398 |
Prospective Natural History Study of Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04285398 |
Recruiting |
SparingVision |
2021-06-01 |
| NCT04284293 |
CNS10-NPC for the Treatment of RP |
https://ClinicalTrials.gov/show/NCT04284293 |
Recruiting |
Cedars-Sinai Medical Center |
2022-04-30 |
| NCT04278131 |
BS01 in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04278131 |
Recruiting |
Bionic Sight LLC |
2022-06-30 |
| NCT04252534 |
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma |
https://ClinicalTrials.gov/show/NCT04252534 |
Completed |
Ankara Universitesi Teknokent |
2019-12-30 |
| NCT04238858 |
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04238858 |
Completed |
Ankara Universitesi Teknokent |
2017-02-28 |
| NCT04234438 |
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser |
https://ClinicalTrials.gov/show/NCT04234438 |
Completed |
Ankara Universitesi Teknokent |
2019-10-30 |
| NCT04224207 |
Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton’s Jelly Derived Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT04224207 |
Completed |
Ankara Universitesi Teknokent |
2019-10-30 |
| NCT04141891 |
Advancing Understanding of Transportation Options |
https://ClinicalTrials.gov/show/NCT04141891 |
Recruiting |
University of Colorado, Denver |
2023-08-01 |
| NCT04129021 |
Multimodal Ophthalmic Imaging |
https://ClinicalTrials.gov/show/NCT04129021 |
Recruiting |
Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts |
2023-06-30 |
| NCT04123626 |
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene |
https://ClinicalTrials.gov/show/NCT04123626 |
Recruiting |
ProQR Therapeutics |
2021-10-07 |
| NCT04120883 |
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO) |
https://ClinicalTrials.gov/show/NCT04120883 |
Recruiting |
University of Michigan |
2022-10-31 |
| NCT04068207 |
Minocycline Treatment in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT04068207 |
Recruiting |
Sun Yat-sen University |
2021-12-01 |
| NCT04008771 |
Intravitreal Injection of SeeQ CdSe 655 Alt Nanoparticles for Patients With Degenerative Retinal Diseases |
https://ClinicalTrials.gov/show/NCT04008771 |
Completed |
2C Tech Corp |
2014-12-19 |
| NCT03999021 |
FIGHT-RP 1 Extension Study |
https://ClinicalTrials.gov/show/NCT03999021 |
Active, not recruiting |
Johns Hopkins University |
2021-06-30 |
| NCT03780257 |
Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene |
https://ClinicalTrials.gov/show/NCT03780257 |
Recruiting |
ProQR Therapeutics |
2021-12-31 |
| NCT03772938 |
Stem Cells Therapy in Degenerative Diseases of the Retina |
https://ClinicalTrials.gov/show/NCT03772938 |
Enrolling by invitation |
Pomeranian Medical University Szczecin |
2020-02-28 |
| NCT03635645 |
Experimental and Clinical Studies of Retinal Stimulation |
https://ClinicalTrials.gov/show/NCT03635645 |
Recruiting |
University of Michigan |
2020-10-31 |
| NCT03444961 |
CAREN Argus Rehab (CARE) Study |
https://ClinicalTrials.gov/show/NCT03444961 |
Completed |
The Cleveland Clinic |
2018-06-20 |
| NCT01256697 |
The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01256697 |
Completed |
Sheba Medical Center |
2009-04-30 |
| NCT01235624 |
Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes |
https://ClinicalTrials.gov/show/NCT01235624 |
Completed |
University Hospital, Montpellier |
2013-04-30 |
| NCT01233609 |
Trial of Oral Valproic Acid for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01233609 |
Completed |
Foundation Fighting Blindness |
2015-12-31 |
| NCT01068561 |
Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT01068561 |
Completed |
University of Sao Paulo |
2010-01-31 |
| NCT01024803 |
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients |
https://ClinicalTrials.gov/show/NCT01024803 |
Completed |
Retina Implant AG |
2017-04-30 |
| NCT01014052 |
Safety/Proof of Concept Study of Oral QLT091001 in Subjects With Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT) Mutations |
https://ClinicalTrials.gov/show/NCT01014052 |
Completed |
QLT Inc. |
2012-08-31 |
| NCT03944239 |
Safety and Efficacy of Subretinal Transplantation of Clinical Human Embryonic Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT03944239 |
Recruiting |
Chinese Academy of Sciences |
2021-10-31 |
| NCT04448860 |
Validation of Standardized Test Protocols to Assess the Impact of Visual Pathologies in Daily Life Activities |
https://ClinicalTrials.gov/show/NCT04448860 |
Recruiting |
Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts |
2023-10-04 |
| NCT00804102 |
Transcorneal Electrical Stimulation Therapy for Retinal Disease |
https://ClinicalTrials.gov/show/NCT00804102 |
Completed |
Okuvision GmbH |
2011-04-30 |
| NCT01680510 |
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil |
https://ClinicalTrials.gov/show/NCT01680510 |
Recruiting |
Sheba Medical Center |
2020-12-31 |
| NCT00717080 |
The Role of Capsular Tension Ring (CTR) in Anterior Capsular Contraction |
https://ClinicalTrials.gov/show/NCT00717080 |
Completed |
Aurolab |
2010-05-31 |
| NCT00661479 |
An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00661479 |
Completed |
Allergan |
2009-12-31 |
| NCT00515814 |
Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors |
https://ClinicalTrials.gov/show/NCT00515814 |
Completed |
Retina Implant AG |
2009-12-31 |
| NCT00461435 |
Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00461435 |
Completed |
Azienda Policlinico Umberto I |
NA |
| NCT00447993 |
A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00447993 |
Completed |
Neurotech Pharmaceuticals |
2009-10-31 |
| NCT00447980 |
A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00447980 |
Completed |
Neurotech Pharmaceuticals |
2010-07-31 |
| NCT00346333 |
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A |
https://ClinicalTrials.gov/show/NCT00346333 |
Completed |
National Eye Institute (NEI) |
2008-12-31 |
| NCT00345917 |
Safety Study in Retinal Transplantation for Retinitis Pigmentosa. |
https://ClinicalTrials.gov/show/NCT00345917 |
Completed |
Radtke, Norman D., M.D. |
2012-03-31 |
| NCT00279500 |
Feasibility Study of a Chronic Retinal Stimulator in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00279500 |
Completed |
Second Sight Medical Products |
2014-12-31 |
| NCT00100230 |
DHA and X-Linked Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00100230 |
Completed |
Retina Foundation of the Southwest |
2012-05-31 |
| NCT00000970 |
A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir |
https://ClinicalTrials.gov/show/NCT00000970 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00029289 |
Effects of Lutein in Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00029289 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |
| NCT00002437 |
The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002437 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002432 |
A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002432 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002377 |
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes |
https://ClinicalTrials.gov/show/NCT00002377 |
Completed |
Hoffmann-La Roche |
2002-12-31 |
| NCT00002356 |
The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes |
https://ClinicalTrials.gov/show/NCT00002356 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002355 |
A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes |
https://ClinicalTrials.gov/show/NCT00002355 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002321 |
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis |
https://ClinicalTrials.gov/show/NCT00002321 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002299 |
The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002299 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002257 |
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS |
https://ClinicalTrials.gov/show/NCT00002257 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002247 |
A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy |
https://ClinicalTrials.gov/show/NCT00002247 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002222 |
A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002222 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002187 |
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00002187 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002169 |
A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00002169 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002156 |
A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) |
https://ClinicalTrials.gov/show/NCT00002156 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002142 |
An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002142 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002135 |
An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access |
https://ClinicalTrials.gov/show/NCT00002135 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002134 |
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00002134 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002125 |
A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) |
https://ClinicalTrials.gov/show/NCT00002125 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002070 |
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis |
https://ClinicalTrials.gov/show/NCT00002070 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002039 |
An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients |
https://ClinicalTrials.gov/show/NCT00002039 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002034 |
A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS |
https://ClinicalTrials.gov/show/NCT00002034 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002025 |
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient |
https://ClinicalTrials.gov/show/NCT00002025 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002016 |
A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis |
https://ClinicalTrials.gov/show/NCT00002016 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002015 |
An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children |
https://ClinicalTrials.gov/show/NCT00002015 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001999 |
A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00001999 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00001061 |
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00001061 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00001034 |
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV |
https://ClinicalTrials.gov/show/NCT00001034 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000989 |
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00000989 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000894 |
Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis |
https://ClinicalTrials.gov/show/NCT00000894 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-06-30 |
| NCT00000836 |
A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) |
https://ClinicalTrials.gov/show/NCT00000836 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000799 |
HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol |
https://ClinicalTrials.gov/show/NCT00000799 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000766 |
CMV Retinitis Retreatment Trial |
https://ClinicalTrials.gov/show/NCT00000766 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1995-09-30 |
| NCT00000726 |
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome |
https://ClinicalTrials.gov/show/NCT00000726 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000698 |
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis |
https://ClinicalTrials.gov/show/NCT00000698 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000693 |
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00000693 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000691 |
A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure |
https://ClinicalTrials.gov/show/NCT00000691 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000688 |
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00000688 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1995-02-28 |
| NCT00000673 |
A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy |
https://ClinicalTrials.gov/show/NCT00000673 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000668 |
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir |
https://ClinicalTrials.gov/show/NCT00000668 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00000665 |
Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component |
https://ClinicalTrials.gov/show/NCT00000665 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
1992-04-30 |
| NCT00063765 |
Evaluation of Safety of Ciliary Neurotrophic Factor Implants in the Eye |
https://ClinicalTrials.gov/show/NCT00063765 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00002330 |
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS |
https://ClinicalTrials.gov/show/NCT00002330 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00065455 |
Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00065455 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001062 |
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes |
https://ClinicalTrials.gov/show/NCT00001062 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00004827 |
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00004827 |
Completed |
FDA Office of Orphan Products Development |
NA |
| NCT00004794 |
Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00004794 |
Completed |
Office of Rare Diseases (ORD) |
NA |
| NCT00000143 |
Studies of Ocular Complications of AIDS (SOCA)–Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) |
https://ClinicalTrials.gov/show/NCT00000143 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
2000-06-30 |
| NCT00000142 |
Studies of the Ocular Complications of AIDS (SOCA)–HPMPC Peripheral CMV Retinitis Trial (HPCRT) |
https://ClinicalTrials.gov/show/NCT00000142 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
1996-02-29 |
| NCT00000136 |
Studies of the Ocular Complications of AIDS (SOCA)–Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) |
https://ClinicalTrials.gov/show/NCT00000136 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
1991-10-31 |
| NCT00000135 |
Studies of the Ocular Complications of AIDS (SOCA)–Monoclonal Antibody CMV Retinitis Trial (MACRT) |
https://ClinicalTrials.gov/show/NCT00000135 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
1996-08-31 |
| NCT00000134 |
Studies of the Ocular Complications of AIDS (SOCA)–Cytomegalovirus Retinitis Retreatment Trial (CRRT) |
https://ClinicalTrials.gov/show/NCT00000134 |
Completed |
Johns Hopkins Bloomberg School of Public Health |
1995-03-31 |
| NCT00000118 |
Ganciclovir Implant Study for Cytomegalovirus Retinitis |
https://ClinicalTrials.gov/show/NCT00000118 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000116 |
Randomized Trial for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00000116 |
Completed |
National Eye Institute (NEI) |
NA |
| NCT00000114 |
Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa |
https://ClinicalTrials.gov/show/NCT00000114 |
Completed |
National Eye Institute (NEI) |
NA |